Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
3.210
-0.120 (-3.60%)
At close: Jul 21, 2025, 4:00 PM
3.340
+0.130 (4.05%)
After-hours: Jul 21, 2025, 7:40 PM EDT

Jasper Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
483218822389125
Upgrade
Market Cap Growth
-85.39%264.33%294.73%-94.26%210.66%-
Upgrade
Enterprise Value
2230-13-2529198
Upgrade
Last Close Price
3.2121.387.894.8378.50100.10
Upgrade
PB Ratio
1.145.201.120.625.5914.37
Upgrade
P/TBV Ratio
1.145.201.120.625.59-
Upgrade
Debt / Equity Ratio
0.060.030.040.100.040.19
Upgrade
Quick Ratio
3.964.707.045.5410.635.09
Upgrade
Current Ratio
4.314.977.195.9110.955.16
Upgrade
Return on Equity (ROE)
-101.34%-101.73%-112.67%-71.44%-78.33%-212.46%
Upgrade
Return on Assets (ROA)
-56.50%-54.52%-60.09%-45.06%-39.35%-51.13%
Upgrade
Return on Capital (ROIC)
-64.57%-65.85%-71.22%-57.12%-55.65%-82.24%
Upgrade
Earnings Yield
-163.38%-22.22%-73.23%-168.98%-7.88%-25.31%
Upgrade
FCF Yield
-145.65%-19.69%-59.45%-208.21%-9.29%-14.60%
Upgrade
Buyback Yield / Dilution
-29.64%-39.72%-186.15%-220.19%-558.67%-
Upgrade
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q